Share Price and Basic Stock Data
Last Updated: January 22, 2026, 10:58 pm
| PEG Ratio | -1.58 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Balaji Amines Ltd operates within the chemicals sector, specifically focusing on organic chemicals. The company’s share price stood at ₹1,234 with a market capitalization of ₹3,999 Cr. In the fiscal year ending March 2024, Balaji Amines reported sales of ₹1,631 Cr, a decline from ₹2,346 Cr in March 2023. This indicates a dip in revenue, reflecting broader challenges within the chemicals industry. Quarterly sales figures show a steady decrease from ₹628 Cr in September 2022 to ₹381 Cr in September 2023, highlighting a concerning trend. The company’s operating profit margin (OPM) has also faced pressure, declining to 20% in March 2023 from 27% in March 2022. The drop in revenue and OPM suggests that Balaji Amines is navigating a difficult market environment, impacted by fluctuating demand and pricing pressures typical in the chemical sector.
Profitability and Efficiency Metrics
Balaji Amines’ profitability metrics reflect a challenging operational landscape. The net profit for the fiscal year ending March 2024 was reported at ₹232 Cr, down from ₹406 Cr in March 2023. The earnings per share (EPS) also fell to ₹63.22 from ₹100.47 during the same period, indicating reduced profitability per share. The company’s return on equity (ROE) stood at 8.83%, which is lower than the sector average, reflecting less efficient use of shareholders’ equity compared to peers. Additionally, the interest coverage ratio (ICR) remained robust at 71.75x, suggesting strong ability to meet interest obligations. However, the operating profit margin (OPM) has decreased significantly, standing at 20% in March 2024 from 27% in March 2022, indicating that while the company maintains operational efficiency, external factors are impacting profitability.
Balance Sheet Strength and Financial Ratios
Balaji Amines’ balance sheet shows a solid foundation despite recent profitability challenges. As of March 2025, the company reported total reserves of ₹1,839 Cr against borrowings of only ₹11 Cr, indicating a very low debt level and strong financial stability. The current ratio stood at 7.25, significantly higher than the typical industry standard, suggesting excellent short-term liquidity. The price-to-book value (P/BV) ratio was recorded at 2.12x, indicating a premium valuation compared to its book value. However, the return on capital employed (ROCE) has declined to 11% in March 2025 from 36% in March 2023, highlighting potential inefficiencies in capital utilization. Overall, while the company maintains a healthy balance sheet, declining ROCE may pose concerns for long-term growth prospects.
Shareholding Pattern and Investor Confidence
Balaji Amines’ shareholding pattern reveals a stable ownership structure that may instill confidence among investors. Promoters hold a significant 54.59% stake, which has shown slight growth from 53.70% in December 2022. Foreign institutional investors (FIIs) hold 4.53% and domestic institutional investors (DIIs) hold 1.52%, indicating modest institutional interest. The public holds 39.37% of the shares, reflecting a balanced distribution. The number of shareholders reported was 1,18,894 as of September 2025, down from a peak of 1,44,990 in September 2023, suggesting some investor attrition amid declining share prices. This trend might raise concerns regarding overall market sentiment towards the stock, especially in light of recent performance metrics.
Outlook, Risks, and Final Insight
Balaji Amines faces a dual-edged sword of opportunities and risks moving forward. Strengths include a strong balance sheet with negligible debt and a robust interest coverage ratio, providing a buffer against market volatility. However, declining profitability metrics and a drop in revenue growth signal challenges that could hinder future performance. Market conditions, particularly in the chemicals sector, remain uncertain, and potential regulatory changes could impact operations. The company’s ability to innovate and adapt to market demands will be crucial. In a scenario where Balaji Amines successfully navigates these challenges while leveraging its financial stability, it could regain profitability and investor confidence. Conversely, continued revenue decline without corrective measures may lead to further erosion of market position and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 51.9 Cr. | 145 | 456/135 | 121 | 392 | 0.07 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,005 Cr. | 8,836 | 14,250/8,150 | 50.7 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 28.0 Cr. | 93.4 | 329/84.1 | 13.9 | 26.9 | 1.07 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 201 Cr. | 251 | 435/163 | 11.1 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,436.00 Cr | 1,428.50 | 54.77 | 334.84 | 0.44% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 628 | 586 | 471 | 464 | 381 | 383 | 414 | 385 | 347 | 313 | 353 | 358 | 341 |
| Expenses | 455 | 458 | 378 | 366 | 327 | 309 | 316 | 319 | 286 | 267 | 293 | 304 | 281 |
| Operating Profit | 173 | 128 | 93 | 98 | 54 | 74 | 98 | 66 | 61 | 46 | 60 | 55 | 60 |
| OPM % | 27% | 22% | 20% | 21% | 14% | 19% | 24% | 17% | 17% | 15% | 17% | 15% | 18% |
| Other Income | 3 | 3 | 6 | 6 | 7 | 8 | 9 | 8 | 9 | 8 | 8 | 9 | 7 |
| Interest | 2 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 11 | 12 | 11 | 11 | 11 | 11 | 12 | 12 | 12 | 12 | 13 | 14 | 14 |
| Profit before tax | 162 | 115 | 85 | 90 | 48 | 70 | 93 | 62 | 57 | 41 | 54 | 49 | 52 |
| Tax % | 27% | 27% | 35% | 25% | 24% | 21% | 22% | 26% | 27% | 24% | 25% | 25% | 28% |
| Net Profit | 119 | 84 | 55 | 68 | 36 | 56 | 72 | 46 | 41 | 31 | 40 | 37 | 37 |
| EPS in Rs | 28.57 | 19.31 | 14.63 | 16.27 | 10.71 | 15.24 | 21.00 | 13.36 | 12.65 | 10.24 | 12.36 | 11.73 | 10.67 |
Last Updated: January 2, 2026, 8:30 am
Below is a detailed analysis of the quarterly data for Balaji Amines Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 341.00 Cr.. The value appears to be declining and may need further review. It has decreased from 358.00 Cr. (Jun 2025) to 341.00 Cr., marking a decrease of 17.00 Cr..
- For Expenses, as of Sep 2025, the value is 281.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 304.00 Cr. (Jun 2025) to 281.00 Cr., marking a decrease of 23.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 55.00 Cr. (Jun 2025) to 60.00 Cr., marking an increase of 5.00 Cr..
- For OPM %, as of Sep 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Jun 2025) to 18.00%, marking an increase of 3.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Jun 2025) to 7.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 14.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Jun 2025) to 52.00 Cr., marking an increase of 3.00 Cr..
- For Tax %, as of Sep 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Jun 2025) to 28.00%, marking an increase of 3.00%.
- For Net Profit, as of Sep 2025, the value is 37.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 37.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 10.67. The value appears to be declining and may need further review. It has decreased from 11.73 (Jun 2025) to 10.67, marking a decrease of 1.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 608 | 616 | 640 | 668 | 858 | 940 | 935 | 1,308 | 2,314 | 2,346 | 1,631 | 1,389 | 1,364 |
| Expenses | 517 | 515 | 514 | 519 | 676 | 747 | 754 | 935 | 1,691 | 1,736 | 1,308 | 1,157 | 1,144 |
| Operating Profit | 91 | 102 | 127 | 149 | 182 | 193 | 181 | 373 | 623 | 609 | 324 | 232 | 220 |
| OPM % | 15% | 17% | 20% | 22% | 21% | 21% | 19% | 29% | 27% | 26% | 20% | 17% | 16% |
| Other Income | 3 | 4 | 3 | 9 | 12 | 4 | 5 | 6 | 15 | 15 | 30 | 33 | 32 |
| Interest | 32 | 35 | 22 | 13 | 9 | 13 | 23 | 18 | 17 | 12 | 6 | 4 | 3 |
| Depreciation | 16 | 20 | 19 | 20 | 19 | 20 | 32 | 34 | 42 | 46 | 45 | 48 | 53 |
| Profit before tax | 46 | 51 | 88 | 126 | 166 | 165 | 131 | 327 | 578 | 567 | 302 | 213 | 195 |
| Tax % | 27% | 35% | 34% | 34% | 32% | 29% | 26% | 25% | 28% | 28% | 23% | 26% | |
| Net Profit | 34 | 33 | 58 | 82 | 113 | 117 | 97 | 243 | 418 | 406 | 232 | 159 | 145 |
| EPS in Rs | 10.34 | 10.25 | 17.78 | 25.42 | 34.93 | 36.27 | 32.34 | 73.51 | 113.71 | 100.47 | 63.22 | 48.62 | 45.00 |
| Dividend Payout % | 10% | 12% | 11% | 9% | 7% | 8% | 10% | 5% | 5% | 10% | 17% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2.94% | 75.76% | 41.38% | 37.80% | 3.54% | -17.09% | 150.52% | 72.02% | -2.87% | -42.86% | -31.47% |
| Change in YoY Net Profit Growth (%) | 0.00% | 78.70% | -34.38% | -3.57% | -34.27% | -20.63% | 167.61% | -78.50% | -74.89% | -39.99% | 11.39% |
Balaji Amines Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | -16% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 8% |
| 3 Years: | -25% |
| TTM: | -22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 12% |
| 3 Years: | -24% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 19% |
| 3 Years: | 14% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 12:20 am
Balance Sheet
Last Updated: December 10, 2025, 2:26 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 195 | 221 | 274 | 356 | 461 | 568 | 652 | 888 | 1,243 | 1,548 | 1,715 | 1,839 | 1,875 |
| Borrowings | 262 | 256 | 173 | 105 | 152 | 227 | 260 | 127 | 101 | 58 | 20 | 11 | 31 |
| Other Liabilities | 158 | 139 | 152 | 168 | 229 | 244 | 195 | 289 | 395 | 351 | 405 | 396 | 418 |
| Total Liabilities | 620 | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 2,146 | 2,252 | 2,331 |
| Fixed Assets | 325 | 341 | 341 | 325 | 316 | 320 | 573 | 543 | 681 | 780 | 896 | 1,003 | 1,058 |
| CWIP | 8 | 3 | 16 | 25 | 123 | 269 | 46 | 173 | 141 | 113 | 205 | 238 | 339 |
| Investments | 20 | 0 | 0 | 0 | 0 | 0 | 48 | 0 | 0 | 73 | 0 | 0 | 0 |
| Other Assets | 267 | 278 | 248 | 284 | 409 | 457 | 446 | 594 | 923 | 996 | 1,046 | 1,011 | 935 |
| Total Assets | 620 | 623 | 605 | 635 | 848 | 1,046 | 1,113 | 1,310 | 1,745 | 1,963 | 2,146 | 2,252 | 2,331 |
Below is a detailed analysis of the balance sheet data for Balaji Amines Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,875.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,839.00 Cr. (Mar 2025) to 1,875.00 Cr., marking an increase of 36.00 Cr..
- For Borrowings, as of Sep 2025, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 11.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 20.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 418.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 396.00 Cr. (Mar 2025) to 418.00 Cr., marking an increase of 22.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,331.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,252.00 Cr. (Mar 2025) to 2,331.00 Cr., marking an increase of 79.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,058.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,003.00 Cr. (Mar 2025) to 1,058.00 Cr., marking an increase of 55.00 Cr..
- For CWIP, as of Sep 2025, the value is 339.00 Cr.. The value appears strong and on an upward trend. It has increased from 238.00 Cr. (Mar 2025) to 339.00 Cr., marking an increase of 101.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 935.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,011.00 Cr. (Mar 2025) to 935.00 Cr., marking a decrease of 76.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,331.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,252.00 Cr. (Mar 2025) to 2,331.00 Cr., marking an increase of 79.00 Cr..
Notably, the Reserves (1,875.00 Cr.) exceed the Borrowings (31.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -171.00 | -154.00 | -46.00 | 44.00 | 30.00 | -34.00 | -79.00 | 246.00 | 522.00 | 551.00 | 304.00 | 221.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 79 | 71 | 71 | 68 | 73 | 65 | 81 | 85 | 93 | 59 | 71 | 72 |
| Inventory Days | 87 | 114 | 80 | 106 | 70 | 116 | 77 | 64 | 66 | 89 | 116 | 128 |
| Days Payable | 83 | 48 | 58 | 55 | 56 | 60 | 42 | 44 | 54 | 18 | 31 | 32 |
| Cash Conversion Cycle | 83 | 136 | 93 | 119 | 87 | 120 | 116 | 104 | 105 | 129 | 156 | 168 |
| Working Capital Days | -17 | 7 | 12 | 42 | 31 | 47 | 55 | 88 | 88 | 89 | 114 | 120 |
| ROCE % | 18% | 18% | 23% | 30% | 32% | 24% | 18% | 35% | 49% | 36% | 17% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Nifty Smallcap 250 Index Fund | 5,925 | 0.19 | 1.29 | 5,925 | 2025-04-22 17:25:41 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 3,723 | 0.19 | 0.81 | 3,723 | 2025-04-22 17:25:41 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 2,706 | 0.19 | 0.59 | 2,706 | 2025-04-22 17:25:41 | 0% |
| ICICI Prudential Nifty Smallcap 250 Index Fund | 1,468 | 0.19 | 0.32 | 1,468 | 2025-04-22 17:25:41 | 0% |
| HDFC NIFTY Smallcap 250 ETF | 671 | 0.19 | 0.15 | 671 | 2025-04-22 17:25:41 | 0% |
| HDFC Nifty Smallcap 250 Index Fund | 520 | 0.19 | 0.11 | 520 | 2025-04-22 17:25:41 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 416 | 0.02 | 0.09 | 416 | 2025-04-22 17:25:41 | 0% |
| Edelweiss Nifty Smallcap 250 Index Fund | 115 | 0.18 | 0.03 | 115 | 2025-04-22 17:25:41 | 0% |
| ICICI Prudential S&P BSE 500 ETF | 97 | 0.02 | 0.02 | 97 | 2025-04-22 17:25:41 | 0% |
| HDFC S&P BSE 500 ETF | 5 | 0.02 | 0 | 5 | 2025-04-22 17:25:41 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 48.62 | 63.22 | 100.47 | 113.71 | 73.51 |
| Diluted EPS (Rs.) | 48.62 | 63.22 | 100.47 | 113.71 | 73.51 |
| Cash EPS (Rs.) | 63.90 | 85.70 | 139.27 | 141.94 | 85.77 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 569.44 | 584.32 | 524.11 | 405.81 | 280.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 569.44 | 584.32 | 524.11 | 405.81 | 280.83 |
| Revenue From Operations / Share (Rs.) | 431.19 | 506.62 | 726.95 | 716.14 | 404.76 |
| PBDIT / Share (Rs.) | 81.90 | 109.06 | 192.70 | 196.72 | 117.06 |
| PBIT / Share (Rs.) | 66.95 | 95.06 | 178.63 | 183.76 | 106.44 |
| PBT / Share (Rs.) | 65.81 | 93.07 | 174.94 | 178.48 | 100.80 |
| Net Profit / Share (Rs.) | 48.95 | 71.70 | 125.21 | 128.98 | 75.15 |
| NP After MI And SOA / Share (Rs.) | 48.62 | 63.22 | 100.47 | 113.71 | 73.51 |
| PBDIT Margin (%) | 18.99 | 21.52 | 26.50 | 27.46 | 28.92 |
| PBIT Margin (%) | 15.52 | 18.76 | 24.57 | 25.65 | 26.29 |
| PBT Margin (%) | 15.26 | 18.37 | 24.06 | 24.92 | 24.90 |
| Net Profit Margin (%) | 11.35 | 14.15 | 17.22 | 18.01 | 18.56 |
| NP After MI And SOA Margin (%) | 11.27 | 12.47 | 13.82 | 15.87 | 18.16 |
| Return on Networth / Equity (%) | 8.53 | 11.89 | 20.94 | 29.47 | 26.63 |
| Return on Capital Employeed (%) | 10.22 | 15.41 | 31.91 | 40.87 | 32.30 |
| Return On Assets (%) | 6.99 | 9.54 | 16.58 | 19.65 | 18.17 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.04 | 0.09 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.03 | 0.05 | 0.11 |
| Asset Turnover Ratio (%) | 0.63 | 0.79 | 1.23 | 1.27 | 1.02 |
| Current Ratio (X) | 7.25 | 6.70 | 6.92 | 2.49 | 2.38 |
| Quick Ratio (X) | 5.14 | 4.78 | 4.89 | 1.96 | 1.92 |
| Inventory Turnover Ratio (X) | 4.98 | 3.11 | 4.80 | 7.20 | 5.98 |
| Dividend Payout Ratio (NP) (%) | 22.62 | 15.81 | 5.97 | 3.51 | 0.81 |
| Dividend Payout Ratio (CP) (%) | 17.30 | 12.94 | 5.23 | 3.15 | 0.71 |
| Earning Retention Ratio (%) | 77.38 | 84.19 | 94.03 | 96.49 | 99.19 |
| Cash Earning Retention Ratio (%) | 82.70 | 87.06 | 94.77 | 96.85 | 99.29 |
| Interest Coverage Ratio (X) | 71.75 | 54.85 | 52.15 | 37.27 | 20.74 |
| Interest Coverage Ratio (Post Tax) (X) | 43.88 | 37.06 | 34.89 | 25.44 | 14.31 |
| Enterprise Value (Cr.) | 3742.00 | 6473.73 | 6259.55 | 9490.08 | 5807.49 |
| EV / Net Operating Revenue (X) | 2.68 | 3.94 | 2.66 | 4.09 | 4.43 |
| EV / EBITDA (X) | 14.10 | 18.32 | 10.03 | 14.89 | 15.31 |
| MarketCap / Net Operating Revenue (X) | 2.80 | 4.03 | 2.67 | 4.05 | 4.36 |
| Retention Ratios (%) | 77.37 | 84.18 | 94.02 | 96.48 | 99.18 |
| Price / BV (X) | 2.12 | 3.85 | 4.05 | 7.52 | 6.39 |
| Price / Net Operating Revenue (X) | 2.80 | 4.03 | 2.67 | 4.05 | 4.36 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.03 | 0.04 |
After reviewing the key financial ratios for Balaji Amines Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 48.62. This value is within the healthy range. It has decreased from 63.22 (Mar 24) to 48.62, marking a decrease of 14.60.
- For Diluted EPS (Rs.), as of Mar 25, the value is 48.62. This value is within the healthy range. It has decreased from 63.22 (Mar 24) to 48.62, marking a decrease of 14.60.
- For Cash EPS (Rs.), as of Mar 25, the value is 63.90. This value is within the healthy range. It has decreased from 85.70 (Mar 24) to 63.90, marking a decrease of 21.80.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 569.44. It has decreased from 584.32 (Mar 24) to 569.44, marking a decrease of 14.88.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 569.44. It has decreased from 584.32 (Mar 24) to 569.44, marking a decrease of 14.88.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 431.19. It has decreased from 506.62 (Mar 24) to 431.19, marking a decrease of 75.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 81.90. This value is within the healthy range. It has decreased from 109.06 (Mar 24) to 81.90, marking a decrease of 27.16.
- For PBIT / Share (Rs.), as of Mar 25, the value is 66.95. This value is within the healthy range. It has decreased from 95.06 (Mar 24) to 66.95, marking a decrease of 28.11.
- For PBT / Share (Rs.), as of Mar 25, the value is 65.81. This value is within the healthy range. It has decreased from 93.07 (Mar 24) to 65.81, marking a decrease of 27.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 48.95. This value is within the healthy range. It has decreased from 71.70 (Mar 24) to 48.95, marking a decrease of 22.75.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 48.62. This value is within the healthy range. It has decreased from 63.22 (Mar 24) to 48.62, marking a decrease of 14.60.
- For PBDIT Margin (%), as of Mar 25, the value is 18.99. This value is within the healthy range. It has decreased from 21.52 (Mar 24) to 18.99, marking a decrease of 2.53.
- For PBIT Margin (%), as of Mar 25, the value is 15.52. This value is within the healthy range. It has decreased from 18.76 (Mar 24) to 15.52, marking a decrease of 3.24.
- For PBT Margin (%), as of Mar 25, the value is 15.26. This value is within the healthy range. It has decreased from 18.37 (Mar 24) to 15.26, marking a decrease of 3.11.
- For Net Profit Margin (%), as of Mar 25, the value is 11.35. This value exceeds the healthy maximum of 10. It has decreased from 14.15 (Mar 24) to 11.35, marking a decrease of 2.80.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.27. This value is within the healthy range. It has decreased from 12.47 (Mar 24) to 11.27, marking a decrease of 1.20.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.53. This value is below the healthy minimum of 15. It has decreased from 11.89 (Mar 24) to 8.53, marking a decrease of 3.36.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.22. This value is within the healthy range. It has decreased from 15.41 (Mar 24) to 10.22, marking a decrease of 5.19.
- For Return On Assets (%), as of Mar 25, the value is 6.99. This value is within the healthy range. It has decreased from 9.54 (Mar 24) to 6.99, marking a decrease of 2.55.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has decreased from 0.79 (Mar 24) to 0.63, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 7.25. This value exceeds the healthy maximum of 3. It has increased from 6.70 (Mar 24) to 7.25, marking an increase of 0.55.
- For Quick Ratio (X), as of Mar 25, the value is 5.14. This value exceeds the healthy maximum of 2. It has increased from 4.78 (Mar 24) to 5.14, marking an increase of 0.36.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.98. This value is within the healthy range. It has increased from 3.11 (Mar 24) to 4.98, marking an increase of 1.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 22.62. This value is within the healthy range. It has increased from 15.81 (Mar 24) to 22.62, marking an increase of 6.81.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 17.30. This value is below the healthy minimum of 20. It has increased from 12.94 (Mar 24) to 17.30, marking an increase of 4.36.
- For Earning Retention Ratio (%), as of Mar 25, the value is 77.38. This value exceeds the healthy maximum of 70. It has decreased from 84.19 (Mar 24) to 77.38, marking a decrease of 6.81.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 82.70. This value exceeds the healthy maximum of 70. It has decreased from 87.06 (Mar 24) to 82.70, marking a decrease of 4.36.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 71.75. This value is within the healthy range. It has increased from 54.85 (Mar 24) to 71.75, marking an increase of 16.90.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 43.88. This value is within the healthy range. It has increased from 37.06 (Mar 24) to 43.88, marking an increase of 6.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,742.00. It has decreased from 6,473.73 (Mar 24) to 3,742.00, marking a decrease of 2,731.73.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has decreased from 3.94 (Mar 24) to 2.68, marking a decrease of 1.26.
- For EV / EBITDA (X), as of Mar 25, the value is 14.10. This value is within the healthy range. It has decreased from 18.32 (Mar 24) to 14.10, marking a decrease of 4.22.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.80. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 2.80, marking a decrease of 1.23.
- For Retention Ratios (%), as of Mar 25, the value is 77.37. This value exceeds the healthy maximum of 70. It has decreased from 84.18 (Mar 24) to 77.37, marking a decrease of 6.81.
- For Price / BV (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 3.85 (Mar 24) to 2.12, marking a decrease of 1.73.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.80. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 2.80, marking a decrease of 1.23.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balaji Amines Ltd:
- Net Profit Margin: 11.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.22% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.53% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 43.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.14
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.8 (Industry average Stock P/E: 54.77)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.35%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Balaji Towers, No. 9/1/A/1, Hotgi Road, Solapur Maharashtra 413224 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. A Prathap Reddy | Executive Chairman |
| Mr. D Ram Reddy | Managing Director |
| Mr. A Srinivas Reddy | WholeTime Director & CFO |
| Mr. N Rajeshwar Reddy | Whole Time Director |
| Mr. Mohan Kumar Ramakrishna | Independent Director |
| Mr. Adabala Seshagiri Rao | Independent Director |
| Dr. Uma Rajiv Pradhan | Independent Director |
| Dr. Suhasini Yatin Shah | Independent Director |
FAQ
What is the intrinsic value of Balaji Amines Ltd?
Balaji Amines Ltd's intrinsic value (as of 23 January 2026) is ₹922.10 which is 23.79% lower the current market price of ₹1,210.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,915 Cr. market cap, FY2025-2026 high/low of ₹1,946/1,066, reserves of ₹1,875 Cr, and liabilities of ₹2,331 Cr.
What is the Market Cap of Balaji Amines Ltd?
The Market Cap of Balaji Amines Ltd is 3,915 Cr..
What is the current Stock Price of Balaji Amines Ltd as on 23 January 2026?
The current stock price of Balaji Amines Ltd as on 23 January 2026 is ₹1,210.
What is the High / Low of Balaji Amines Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balaji Amines Ltd stocks is ₹1,946/1,066.
What is the Stock P/E of Balaji Amines Ltd?
The Stock P/E of Balaji Amines Ltd is 26.8.
What is the Book Value of Balaji Amines Ltd?
The Book Value of Balaji Amines Ltd is 581.
What is the Dividend Yield of Balaji Amines Ltd?
The Dividend Yield of Balaji Amines Ltd is 0.91 %.
What is the ROCE of Balaji Amines Ltd?
The ROCE of Balaji Amines Ltd is 11.0 %.
What is the ROE of Balaji Amines Ltd?
The ROE of Balaji Amines Ltd is 8.83 %.
What is the Face Value of Balaji Amines Ltd?
The Face Value of Balaji Amines Ltd is 2.00.